http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-730499-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dbb2d7ecbd600cf89fbdd230f4a466c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-52
filingDate 1952-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1955-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-730499-A
titleOfInvention Improvements in or relating to pyrimidine compounds
abstract The invention comprises 2-amino- and 2-acetylamino - 4 - hydroxy - 5 - (41 - chlorophenyl)-6-ethylpyrimidine, and the manufacture thereof by condensing guanidine with ethyl 2 - (41 - chlorophenyl) - 3 - oxopentanoate in a reaction medium consisting of oleum of 15-40 per cent sulphur trioxide content, and, if desired, acetylating the amino group of the product. In examples: (1) guanidine sulphate is condensed with ethyl 2-(41-chlorophenyl)-3-oxopentanoate in 20 per cent oleum; (2) guanidine carbonate is similarly condensed and the product is acetylated with acetic anhydride and pyridine. Specifications 730,472 and 730,539 are referred to. Ethyl 2 - (41 - chlorophenyl) - 3 - oxopentanoate is prepared by controlled hydrolysis of the ethyl imidoester of 2-(41-chlorophenyl)-3-oxopentanoic acid, itself obtainable from the corresponding nitrile produced by condensing ethyl propionate with 4-chlorobenzyl cyanide.
priorityDate 1951-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452789859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454734572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588032

Total number of triples: 31.